CS, K., AF, Z., & SS, H. (2022). Has it come to the time to recommend routine use of alirocumab in patients with acute coronary syndrome? European journal of preventive cardiology, 29(2), e77. https://doi.org/10.1093/eurjpc/zwaa148
Chicago Style (17th ed.) CitationCS, Kow, Zaihan AF, and Hasan SS. "Has It Come to the Time to Recommend Routine Use of Alirocumab in Patients with Acute Coronary Syndrome?" European Journal of Preventive Cardiology 29, no. 2 (2022): e77. https://doi.org/10.1093/eurjpc/zwaa148.
MLA (9th ed.) CitationCS, Kow, et al. "Has It Come to the Time to Recommend Routine Use of Alirocumab in Patients with Acute Coronary Syndrome?" European Journal of Preventive Cardiology, vol. 29, no. 2, 2022, p. e77, https://doi.org/10.1093/eurjpc/zwaa148.